IGM Biosciences, Inc. Common Stock

Go to IGM Biosciences, Inc. Common Stock Website

$1.30

0.00 (0.00%)
Live
Previous Close

$1.3

Day Range

$0 - $0

Previous Day Range

$1.3 - $1.31

Market Cap

$79.0 million USD

Day Vol.

0

Previous Day Vol.

149849

Currency

USD

Primary Exchange

Nasdaq

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for deve...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies involved in recent merger and acquisition transactions.

Related tickers: OLO, SPTN, IGMS.

Read Full Article

IGM Biosciences is discontinuing the development of its autoimmune disease drug candidates imvotamab and IGM-2644 due to insufficient efficacy. The company is also reducing its workforce by 73% and has $183.8 million in cash and investments as of December 31, 2024.

Related tickers: IGMS.

Read Full Article
Trending Tickers

Please sign in to view